CGEM logo

CGEM
Cullinan Oncology Inc

475
Mkt Cap
$880.05M
Volume
388,331.00
52W High
$16.74
52W Low
$5.68
PE Ratio
-3.90
CGEM Fundamentals
Price
$14.54
Prev Close
$15.21
Open
$15.24
50D MA
$13.73
Beta
1.18
Avg. Volume
858,801.32
EPS (Annual)
-$3.72
P/B
2.14
Rev/Employee
$0.00
$235.95
Loading...
Loading...
News
all
press releases
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) have been assigned an average rating of "Moderate Buy" from the ten brokerages that are presently covering the firm, MarketBeat...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Cullinan Therapeutics (NASDAQ:CGEM) Shares Up 6.3% - What's Next?
Cullinan Therapeutics (NASDAQ:CGEM) Trading Up 6.3% - Here's What Happened...
MarketBeat·6d ago
News Placeholder
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the ten ratings firms that are currently covering the stock...
MarketBeat·28d ago
News Placeholder
Cullinan Therapeutics flags 2026 as defining year at Leerink, tees up key CLN-978/CLN-049 data
Cullinan Therapeutics (NASDAQ:CGEM) outlined a milestone-heavy roadmap during a presentation at Leerink Partners' Annual Healthcare Conference in Miami, with management emphasizing 2026 as a...
MarketBeat·30d ago
News Placeholder
Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Expected to Rise, Wedbush Analyst Says
Wedbush increased their price objective on Cullinan Therapeutics from $34.00 to $36.00 and gave the stock an "outperform" rating in a report on Wednesday...
MarketBeat·1mo ago
News Placeholder
Cullinan Therapeutics (NASDAQ:CGEM) Insider Sells $125,440.00 in Stock
Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) insider Jennifer Michaelson sold 8,000 shares of the company's stock in a transaction that occurred on Thursday, March 5th. The stock was...
MarketBeat·1mo ago
News Placeholder
Jennifer Michaelson Sells 8,000 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock
Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) insider Jennifer Michaelson sold 8,000 shares of the firm's stock in a transaction on Thursday, March 5th. The shares were sold at an...
MarketBeat·1mo ago
News Placeholder
Cullinan Therapeutics Maps 2026 Data Catalysts for Autoimmune CLN-978, AML CLN-049 at TD Cowen Conference
Cullinan Therapeutics (NASDAQ:CGEM) executives highlighted upcoming clinical milestones for the company's two high-priority T-cell engager programs during remarks at the 46th Annual TD Cowen...
MarketBeat·1mo ago
News Placeholder
Cullinan Therapeutics (NASDAQ:CGEM) Shares Up 7.6% - Here's Why
Cullinan Therapeutics (NASDAQ:CGEM) Shares Up 7.6% - What's Next...
MarketBeat·1mo ago
News Placeholder
Jennifer Michaelson Sells 1,780 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock
Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) insider Jennifer Michaelson sold 1,780 shares of the business's stock in a transaction that occurred on Wednesday, February 25th. The...
MarketBeat·1mo ago
<
1
2
...
>

Latest CGEM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.